Celgene Corporation
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Celgene Corporation is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Celgene Corporation in the same report. This provides an indication of potential competitors or associated to Celgene Corporation. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


2016-12-30
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H2 2016

    Liver Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape.

    Liver cancer starts in the liver. The risk...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8854IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8854IDB
  • View Report: Research and Experts Market Report: Dysphagia Global Clinical Trials Review, H2, 2016

    Dysphagia Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Dysphagia Global Clinical Trials Review, H2, 2016" provides an overview of Dysphagia clinical trials scenario. This report provides top line data relating to the clinical trials on Dysphagia. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3948CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3948CTIDB
  • View Report: Research and Experts Market Report: Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

    Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of Eosinophilic Esophagitis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3922CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3922CTIDB
  • View Report: Research and Experts Market Report: Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016

    Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016" provides an overview of Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) clinical trials scenario....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3920CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3920CTIDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016

    Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus Infections (AIDS) – Pipeline Review, H2 2016, provides an overview of the Human Immunodeficiency Virus Infections (AIDS) (Infectious...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8867IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8867IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H2 2016

    Multiple Sclerosis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis – Pipeline Review, H2 2016, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.

    Multiple sclerosis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8845IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8845IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2016

    Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lassa Fever (Lassa Hemorrhagic Fever) – Pipeline Review, H2 2016, provides an overview of the Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline...
  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8837IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8837IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Radiculopathy Global Clinical Trials Review, H2, 2016

    Radiculopathy Global Clinical Trials Review, H2, 2016


    2016-11-22
    GlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, H2, 2016" provides an overview of Radiculopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Radiculopathy....
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3916CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3916CTIDB
  • View Report: Research and Experts Market Report: Complex Regional Pain Syndrome Global Clinical Trials Review, H2, 2016

    Complex Regional Pain Syndrome Global Clinical Trials Review, H2, 2016


    2016-11-22
    GlobalData's clinical trial report, “Complex Regional Pain Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Complex Regional Pain Syndrome clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3911CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3911CTIDB
  • View Report: Research and Experts Market Report: Cholangitis Global Clinical Trials Review, H2, 2016

    Cholangitis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Cholangitis Global Clinical Trials Review, H2, 2016" provides an overview of Cholangitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholangitis. Report...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3897CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3897CTIDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016

    Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3879CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3879CTIDB
  • View Report: Research and Experts Market Report: Thymic Carcinoma Global Clinical Trials Review, H2, 2016

    Thymic Carcinoma Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Thymic Carcinoma Global Clinical Trials Review, H2, 2016" provides an overview of Thymic Carcinoma clinical trials scenario. This report provides top line data relating to the clinical trials on Thymic...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3876CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3876CTIDB
  • View Report: Research and Experts Market Report: Encephalopathy - Pipeline Review, H2 2016

    Encephalopathy - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy – Pipeline Review, H2 2016, provides an overview of the Encephalopathy (Central Nervous System) pipeline landscape.

    Encephalopathy is a term...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8810IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8810IDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H2 2016

    Neuroendocrine Tumors - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Pipeline Review, H2 2016, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

    Neuroendocrine tumor begins...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8809IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8809IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2016, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape.

    Bi...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8808IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8808IDB
  • View Report: Research and Experts Market Report: Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5)...

    Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H2 2016’, provides in depth analysis on Carcinoembryonic...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0649TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0649TDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H2 2016

    Hepatocellular Carcinoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatocellular Carcinoma - Pipeline Review, H2 2016, provides an overview of the Hepatocellular Carcinoma (Oncology) pipeline landscape.

    Hepatocellular carcinoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8748IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8748IDB
  • View Report: Research and Experts Market Report: Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016

    Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Extrahepatic Bile Duct Cancer clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3873CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3873CTIDB
  • View Report: Research and Experts Market Report: Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016

    Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Follicular Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Follicular Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3865CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3865CTIDB
  • View Report: Research and Experts Market Report: Hematological Tumor Global Clinical Trials Review, H2, 2016

    Hematological Tumor Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H2, 2016" provides an overview of Hematological Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3862CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3862CTIDB
  • View Report: Research and Experts Market Report: Interleukin 13 (IL13) - Pipeline Review, H2 2016

    Interleukin 13 (IL13) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted pipeline therapeutics.

    The report provides comprehensive information on the Interleukin 13 (IL13)...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0622TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0622TDB
  • View Report: Research and Experts Market Report: Behcet Disease - Pipeline Review, H2 2016

    Behcet Disease - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Behcet Disease – Pipeline Review, H2 2016, provides an overview of the Behcet Disease (Immunology) pipeline landscape.

    Behcet disease (BEH-chets), sometimes...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8734IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8734IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H2 2016

    Metastatic Colorectal Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Colorectal Cancer (Oncology) pipeline landscape.

    Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8728IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8728IDB
  • View Report: Research and Experts Market Report: Neuroblastoma - Pipeline Review, H2 2016

    Neuroblastoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma – Pipeline Review, H2 2016, provides an overview of the Neuroblastoma (Oncology) pipeline landscape.

    Neuroblastoma is the cancer of the nerve...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8722IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8722IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2016, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8721IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8721IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H2 2016

    Follicular Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Follicular Lymphoma – Pipeline Review, H2 2016, provides an overview of the Follicular Lymphoma (Oncology) pipeline landscape.

    Follicular lymphoma is a common...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8717IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8717IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8713IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8713IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H2 2016

    Small-Cell Lung Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.

    Small cell lung cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8706IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8706IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.

    The...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8705IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8705IDB
  • View Report: Research and Experts Project Profile: Celgene Corporation - Strategy, SWOT and Corporate Finance Report

    Celgene Corporation - Strategy, SWOT and Corporate Finance Report


    2017-01-31
    Celgene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions,...
  • Project Profile
  • Life Sciences
  • United States
  • $175.00
  • Report 05IK-7900606C-967C-43A8-ADDC-8A has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-7900606C-967C-43A8-ADDC-8A
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC...

    Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0612TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0612TDB
  • View Report: Research and Experts Market Report: Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2016

    Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola Hemorrhagic Fever) – Pipeline Review, H2 2016, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious...
  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8704IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8704IDB
  • View Report: Research and Experts Market Report: Diabetic Foot Ulcers - Pipeline Review, H2 2016

    Diabetic Foot Ulcers - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Foot Ulcers – Pipeline Review, H2 2016, provides an overview of the Diabetic Foot Ulcers (Metabolic Disorders) pipeline landscape.

    Diabetic foot ulcers...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8696IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8696IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8687IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8687IDB
  • View Report: Research and Experts Market Report: Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016

    Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Bone Marrow Transplant Rejection clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3823CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3823CTIDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H2 2016

    Tuberculosis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H2 2016, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape.

    Tuberculosis, commonly known as TB,...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8686IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8686IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H2 2016

    Psoriatic Arthritis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriatic Arthritis – Pipeline Review, H2 2016, provides an overview of the Psoriatic Arthritis (Musculoskeletal Disorders) pipeline landscape.

    Psoriatic arthritis...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8680IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8680IDB
  • View Report: Research and Experts Market Report: Chondrosarcoma - Pipeline Review, H2 2016

    Chondrosarcoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma – Pipeline Review, H2 2016, provides an overview of the Chondrosarcoma (Oncology) pipeline landscape.

    Chondrosarcoma is a malignant cancer whose...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8674IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8674IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8673IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8673IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H2 2016

    Malaria - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria – Pipeline Review, H2 2016, provides an overview of the Malaria (Infectious Disease) pipeline landscape.

    Malaria is a life-threatening blood disease...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8670IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8670IDB
  • View Report: Research and Experts Market Report: Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2016

    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Arterial Disease (PAD) Peripheral Vascular Disease (PVD) – Pipeline Review, H2 2016, provides an overview of the Peripheral Arterial Disease (PAD)...
  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8665IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8665IDB
  • View Report: Research and Experts Market Report: Ewing Sarcoma - Pipeline Review, H2 2016

    Ewing Sarcoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ewing Sarcoma – Pipeline Review, H2 2016, provides an overview of the Ewing Sarcoma (Oncology) pipeline landscape.

    Ewing's sarcoma is a primary bone cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8657IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8657IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathy - Pipeline Review, H2 2016

    Diabetic Neuropathy - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Neuropathy – Pipeline Review, H2 2016, provides an overview of the Diabetic Neuropathy (Metabolic Disorders) pipeline landscape.

    Diabetic neuropathy,...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8653IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8653IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.

    Acute lymphocytic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8640IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8640IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis – Pipeline Review, H2 2016, provides an overview of the Ankylosing Spondylitis (Musculoskeletal Disorders) pipeline landscape.

    Ankylosing...

  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8639IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8639IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016" provides an overview of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) clinical trials scenario. This report provides top...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3814CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3814CTIDB
  • View Report: Research and Experts Market Report: Behcet Disease Global Clinical Trials Review, H2, 2016

    Behcet Disease Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Behcet Disease Global Clinical Trials Review, H2, 2016" provides an overview of Behcet Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Behcet Disease....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3805CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3805CTIDB
  • View Report: Research and Experts Market Report: Sphingosine 1 Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor...

    Sphingosine 1 Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct’s, ‘Sphingosine 1 Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) – Pipeline Review, - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0585TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0585TDB
  • View Report: Research and Experts Market Report: Gliosarcoma - Pipeline Review, H2 2016

    Gliosarcoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gliosarcoma – Pipeline Review, H2 2016, provides an overview of the Gliosarcoma (Oncology) pipeline landscape.

    Gliosarcoma is a type of brain tumor that originates...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8633IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8633IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2016

    Bladder Cancer - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H2 2016, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.

    Bladder cancer occurs in tissues of the...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8622IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8622IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2016, provides an overview of the Diffuse Large B-Cell Lymphoma (Oncology) pipeline landscape.

    Diffuse large...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8656IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8656IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis – Pipeline Review, H2 2016, provides an overview of the Idiopathic Pulmonary Fibrosis (Respiratory) pipeline landscape.

    Idiopathic...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8608IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8608IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H2 2016

    Ulcerative Colitis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ulcerative Colitis – Pipeline Review, H2 2016, provides an overview of the Ulcerative Colitis (Gastrointestinal) pipeline landscape.

    Ulcerative Colitis (Colitis...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8598IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8598IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Eosinophilic Esophagitis - Pipeline Review, H2 2016

    Eosinophilic Esophagitis - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Eosinophilic Esophagitis – Pipeline Review, H2 2016, provides an overview of the Eosinophilic Esophagitis (Gastrointestinal) pipeline landscape.

    Eosinophilic...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8557IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8557IDB
  • View Report: Research and Experts Market Report: Pancreatic Ductal Adenocarcinoma - Pipeline Review, H2 2016

    Pancreatic Ductal Adenocarcinoma - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Ductal Adenocarcinoma – Pipeline Review, H2 2016, provides an overview of the Pancreatic Ductal Adenocarcinoma (Oncology) pipeline landscape.

    Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8532IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8532IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H2 2016

    Waldenstrom Macroglobulinemia - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Waldenstrom Macroglobulinemia – Pipeline Review, H2 2016, provides an overview of the Waldenstrom Macroglobulinemia (Oncology) pipeline landscape.

    Waldenstrom...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8527IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8527IDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma - Pipeline Review, H2 2016

    Rhabdomyosarcoma - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhabdomyosarcoma – Pipeline Review, H2 2016, provides an overview of the Rhabdomyosarcoma (Oncology) pipeline landscape.

    Rhabdomyosarcoma (RMS) is a malignant...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8513IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8513IDB
  • View Report: Research and Experts Market Report: Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2016

    Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Polycythemia Vera Myelofibrosis (PPV-MF) – Pipeline Review, H2 2016, provides an overview of the Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8511IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8511IDB
  • View Report: Research and Experts Market Report: Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2016

    Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Ischemic Cerebral Stroke Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic Cerebral Stroke clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3758CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3758CTIDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2016" provides an overview of Crohn's Disease (Regional Enteritis) clinical trials scenario. This report provides top...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3756CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3756CTIDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016

    Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Pulmonary Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IC-GDHC3749CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3749CTIDB
  • View Report: Research and Experts Market Report: Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor...

    Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0548TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0548TDB
  • View Report: Research and Experts Market Report: Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2016

    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2016’, provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) pipeline...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8501IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8501IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H2 2016

    Psoriasis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8494IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8494IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H2 2016

    Pulmonary Fibrosis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pulmonary...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8475IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8475IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

    Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016" provides an overview of Multiple Myeloma (Kahler Disease) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3734CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3734CTIDB
  • View Report: Research and Experts Market Report: Supratentorial Glioma Global Clinical Trials Review, H2, 2016

    Supratentorial Glioma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Supratentorial Glioma Global Clinical Trials Review, H2, 2016" provides an overview of Supratentorial Glioma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3733CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3733CTIDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016

    Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Peripheral T-Cell Lymphomas (PTCL) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral T-Cell Lymphomas (PTCL) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3732CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3732CTIDB
  • View Report: Research and Experts Market Report: Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016

    Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016" provides an overview of Subependymal Giant Cell Astrocytoma clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3731CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3731CTIDB
  • View Report: Research and Experts Market Report: Mycosis Fungoides Global Clinical Trials Review, H2, 2016

    Mycosis Fungoides Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Mycosis Fungoides Global Clinical Trials Review, H2, 2016" provides an overview of Mycosis Fungoides clinical trials scenario. This report provides top line data relating to the clinical trials on Mycosis...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3729CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3729CTIDB
  • View Report: Research and Experts Market Report: Neoplastic Syndrome Global Clinical Trials Review, H2, 2016

    Neoplastic Syndrome Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Neoplastic Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Neoplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3728CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3728CTIDB
  • View Report: Research and Experts Market Report: Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016

    Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of Natural Killer Cell Lymphomas clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3727CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3727CTIDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016

    Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Multiple Myeloma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3725CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3725CTIDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016

    Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016" provides an overview of Transitional Cell Cancer (Urothelial Cell Cancer) clinical trials scenario. This report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3724CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3724CTIDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3719CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3719CTIDB
  • View Report: Research and Experts Market Report: T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

    T-Cell Lymphomas Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Lymphomas clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3718CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3718CTIDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia Global Clinical Trials Review, H2, 2016

    T-Cell Leukemia Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3717CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3717CTIDB
  • View Report: Research and Experts Market Report: Thalassemia Global Clinical Trials Review, H2, 2016

    Thalassemia Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Thalassemia Global Clinical Trials Review, H2, 2016" provides an overview of Thalassemia clinical trials scenario. This report provides top line data relating to the clinical trials on Thalassemia. Report...
  • Market Report
  • Hematology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3706CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3706CTIDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016

    Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016" provides an overview of Graft Versus Host Disease (GVHD) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3697CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3697CTIDB
  • View Report: Research and Experts Market Report: Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2016

    Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2016" provides an overview of Cutaneous Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3695CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3695CTIDB
  • View Report: Research and Experts Market Report: Lupus Erythematosus Global Clinical Trials Review, H2, 2016

    Lupus Erythematosus Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Lupus Erythematosus Global Clinical Trials Review, H2, 2016" provides an overview of Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3694CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3694CTIDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8436IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8436IDB
  • View Report: Research and Experts Market Report: Nasopharyngeal Cancer - Pipeline Review, H2 2016

    Nasopharyngeal Cancer - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H2 2016’, provides an overview of the Nasopharyngeal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8421IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8421IDB
  • View Report: Research and Experts Market Report: DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016

    DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016’, provides in depth analysis on DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0501TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0501TDB
  • View Report: Research and Experts Market Report: Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016

    Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2016’, provides an overview of the Metastatic Hepatocellular Carcinoma (HCC) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8419IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8419IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016

    Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016" provides an overview of Glioblastoma Multiforme (GBM) clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3658CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3658CTIDB
  • View Report: Research and Experts Market Report: Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47)...

    Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6 or CD47) - Pipeline Review, H2 2016’, provides in depth analysis on Leukocyte Surface Antigen...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0480TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0480TDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer - Pipeline Review, H2 2016

    Medullary Thyroid Cancer - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H2 2016’, provides an overview of the Medullary Thyroid Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8369IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8369IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8354IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8354IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8349IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8349IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2016

    Mantle Cell Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Mantle Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mantle...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8348IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8348IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Pipeline Review, H2 2016

    Atopic Dermatitis - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H2 2016’, provides an overview of the Atopic Dermatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atopic...

  • Market Report
  • Dermatology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8341IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8341IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2016

    Indolent Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8340IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8340IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8339IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8339IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma - Current and Future Players

    Multiple Myeloma - Current and Future Players


    2015-11-01
    GlobalData has released its pharma report, “Multiple Myeloma - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Multiple Myeloma Market. The report...
  • Market Report
  • Oncology
  • Global
  • $2,995.00
  • Report 05IC-GDHC1051FPR has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC1051FPR
  • View Report: Research and Experts Market Report: Telangiectasis Global Clinical Trials Review, H2, 2016

    Telangiectasis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Telangiectasis Global Clinical Trials Review, H2, 2016" provides an overview of Telangiectasis clinical trials scenario. This report provides top line data relating to the clinical trials on Telangiectasis. Report includes...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3605CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3605CTIDB
  • View Report: Research and Experts Market Report: Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016

    Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsing Multiple Sclerosis (RMS) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3558CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3558CTIDB
  • View Report: Research and Experts Market Report: Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2016

    Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2016" provides an overview of Metachromatic Leukodystrophy (MLD) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3548CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3548CTIDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase SYK (Spleen Tyrosine Kinase or p72 Syk or SYK or EC 2.7.10.2) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0404TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0404TDB
  • View Report: Research and Experts Market Report: Thrombocythaemia Myelofibrosis - Pipeline Review, H2 2016

    Thrombocythaemia Myelofibrosis - Pipeline Review, H2 2016


    2016-07-20
    ‘Thrombocythaemia Myelofibrosis - Pipeline Review, H2 2016’, provides an overview of the Thrombocythaemia Myelofibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Thrombocythaemia...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8245IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8245IDB
  • View Report: Research and Experts Market Report: Diabetic Peripheral Neuropathy - Pipeline Review, H2 2016

    Diabetic Peripheral Neuropathy - Pipeline Review, H2 2016


    2016-07-20
    ‘Diabetic Peripheral Neuropathy - Pipeline Review, H2 2016’, provides an overview of the Diabetic Peripheral Neuropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic Peripheral...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8244IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8244IDB
  • View Report: Research and Experts Market Report: Erosive Oral Lichen Planus Global Clinical Trials Review, H2, 2016

    Erosive Oral Lichen Planus Global Clinical Trials Review, H2, 2016


    2016-07-13
    Clinical trial report, “Erosive Oral Lichen Planus Global Clinical Trials Review, H2, 2016" provides an overview of Erosive Oral Lichen Planus clinical trials scenario. This report provides top line data relating to the clinical trials on Erosive...
  • Market Report
  • Mouth And Dental Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3547CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3547CTIDB
  • View Report: Research and Experts Market Report: Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H1, 2016

    Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Hypoxic-Ischemic Encephalopathy Global Clinical Trials Review, H1, 2016" provides an overview of Hypoxic-Ischemic Encephalopathy clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3543CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3543CTIDB
  • View Report: Research and Experts Market Report: Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2016

    Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Globoid Cell Leukodystrophy (Krabbe Disease) Global Clinical Trials Review, H1, 2016" provides an overview of Globoid Cell Leukodystrophy (Krabbe Disease) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3532CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3532CTIDB
  • View Report: Research and Experts Market Report: Encephalopathy Global Clinical Trials Review, H1, 2016

    Encephalopathy Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Encephalopathy Global Clinical Trials Review, H1, 2016" provides an overview of Encephalopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Encephalopathy. Report includes...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3529CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3529CTIDB
  • View Report: Research and Experts Market Report: Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016

    Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Primary Systemic Amyloidosis Global Clinical Trials Review, H1, 2016" provides an overview of Primary Systemic Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3513CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3513CTIDB
  • View Report: Research and Experts Market Report: Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Global Clinical Trials Review, H1, 2016

    Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Global Clinical Trials Review, H1, 2016" provides an overview of Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) clinical trials scenario. This...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3511CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3511CTIDB
  • View Report: Research and Experts Market Report: Mitogen-Activated Protein Kinase 8 (c-jun-N-Terminal Kinase 1 or JNK-46 or Stress-Activated Protein Kinase JNK1 or EC 2.7.11.24)...

    Mitogen-Activated Protein Kinase 8 (c-jun-N-Terminal Kinase 1 or JNK-46 or Stress-Activated Protein Kinase JNK1 or EC 2.7.11.24) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Mitogen-Activated Protein Kinase 8 (c-jun-N-Terminal Kinase 1 or JNK-46 or Stress-Activated Protein Kinase JNK1 or EC 2.7.11.24) - Pipeline Review, H1 2016’, provides in depth analysis on Mitogen-Activated Protein...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0220TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0220TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: HIV / AIDS - Pipeline Review, H1 2016

    HIV / AIDS - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2016’, provides an overview of the HIV / AIDS pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for HIV / AIDS, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7958IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7958IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H1, 2016

    Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H1, 2016" provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) clinical trials scenario. This report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3509CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3509CTIDB
  • View Report: Research and Experts Market Report: Hyperbilirubinemia Global Clinical Trials Review, H1, 2016

    Hyperbilirubinemia Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Hyperbilirubinemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperbilirubinemia clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3505CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3505CTIDB
  • View Report: Research and Experts Market Report: Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5)...

    Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2016’, provides in depth analysis on Carcinoembryonic...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0137TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0137TDB
  • View Report: Research and Experts Market Report: Interleukin 13 (IL13) - Pipeline Review, H1 2016

    Interleukin 13 (IL13) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted pipeline therapeutics.

    The report provides comprehensive information on the Interleukin 13 (IL13),...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0124TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0124TDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7953IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7953IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016

    Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Small-Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3500CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3500CTIDB
  • View Report: Research and Experts Market Report: Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016

    Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016" provides an overview of Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3499CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3499CTIDB
  • View Report: Research and Experts Market Report: AIDS - Related Cancer Global Clinical Trials Review, H1, 2016

    AIDS - Related Cancer Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “AIDS - Related Cancer Global Clinical Trials Review, H1, 2016" provides an overview of AIDS - Related Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3498CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3498CTIDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

    B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Chronic Lymphocytic Leukemia clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3497CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3497CTIDB
  • View Report: Research and Experts Market Report: AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2016

    AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of AIDS - Related Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3496CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3496CTIDB
  • View Report: Research and Experts Market Report: Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016

    Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016" provides an overview of Anaplastic Large Cell Lymphoma (ALCL) clinical trials scenario. This report provides top line data...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3495CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3495CTIDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3492CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3492CTIDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3491CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3491CTIDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3485CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3485CTIDB
  • View Report: Research and Experts Market Report: Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine...

    Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Tyrosine-Protein Kinase BTK (Bruton Agammaglobulinemia Tyrosine Kinase or B-Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or EC 2.7.10.2) - Pipeline Review, H1 2016’, provides in depth analysis on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0101TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0101TDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2016

    Liver Cancer - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liver Cancer, complete...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7964IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7964IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7963IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7963IDB
  • View Report: Research and Experts Market Report: Psoriasis - Current and Future Players

    Psoriasis - Current and Future Players


    2016-04-13
    GlobalData has released its pharma report, “Psoriasis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Psoriasis Market. The report identifies...
  • Market Report
  • Life Sciences
  • Global
  • $2,995.00
  • Report 05IC-GDHC1044FPR has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC1044FPR
  • View Report: Research and Experts Market Report: Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016

    Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2016" provides an overview of Chemotherapy Induced Anemia clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3480CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3480CTIDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016

    Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3477CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3477CTIDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3473CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3473CTIDB
  • View Report: Research and Experts Market Report: Brenner Tumor Global Clinical Trials Review, H1, 2016

    Brenner Tumor Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2016" provides an overview of Brenner Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Brenner Tumor....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3471CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3471CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2024


    2016-04-13
    Psoriasis (PsO) is an incurable genetic, systemic, inflammatory, and chronic skin disorder with an overall prevalence of 2-3% worldwide. Specifically, adult plaque psoriasis, the most common form of Psoriasis, is the focus of this report. Although not...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC119PIDR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC119PIDR
  • View Report: Research and Experts Market Report: Amyloidosis Global Clinical Trials Review, H1, 2016

    Amyloidosis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Amyloidosis Global Clinical Trials Review, H1, 2016" provides an overview of Amyloidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3467CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3467CTIDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016

    Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3449CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3449CTIDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma Global Clinical Trials Review, H1, 2016

    Indolent Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Indolent Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Indolent Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Indolent...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3447CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3447CTIDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diffuse Large B-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Diffuse Large B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3444CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3444CTIDB
  • View Report: Research and Experts Market Report: Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016

    Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Cutaneous T-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3443CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3443CTIDB
  • View Report: Research and Experts Market Report: B-Cell Leukemia Global Clinical Trials Review, H1, 2016

    B-Cell Leukemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “B-Cell Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3442CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3442CTIDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

    Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016" provides an overview of Systemic Sclerosis (Scleroderma) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3441CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3441CTIDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016

    Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H1, 2016" provides an overview of Idiopathic Pulmonary Fibrosis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3427CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3427CTIDB
  • View Report: Research and Experts Market Report: Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2016

    Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetic Foot Ulcers Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Foot Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3425CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3425CTIDB
  • View Report: Research and Experts Market Report: Oligodendroglioma Global Clinical Trials Review, H1, 2016

    Oligodendroglioma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2016" provides an overview of Oligodendroglioma clinical trials scenario. This report provides top line data relating to the clinical trials on Oligodendro...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3419CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3419CTIDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma Global Clinical Trials Review, H1, 2016

    Follicular Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Follicular Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3418CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3418CTIDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3417CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3417CTIDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer Global Clinical Trials Review, H1, 2016

    Pancreatic Cancer Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3415CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3415CTIDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hodgkin...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3414CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3414CTIDB
  • View Report: Research and Experts Market Report: Sphingosine 1-Phosphate Receptor 1 (S1P Receptor 1 or Endothelial Differentiation G-Protein Coupled Receptor 1 or Sphingosine 1-Phosphate...

    Sphingosine 1-Phosphate Receptor 1 (S1P Receptor 1 or Endothelial Differentiation G-Protein Coupled Receptor 1 or Sphingosine 1-Phosphate Receptor Edg-1 or CD363 or S1PR1 or CHEDG1 or EDG1) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Sphingosine 1-Phosphate Receptor 1 (S1P Receptor 1 or Endothelial Differentiation G-Protein Coupled Receptor 1 or Sphingosine 1-Phosphate Receptor Edg-1 or CD363 or S1PR1 or CHEDG1 or EDG1) - Pipeline Review, H1 2016’,...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0095TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0095TDB
  • View Report: Research and Experts Market Report: Lassa Fever - Pipeline Review, H1 2016

    Lassa Fever - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Lassa Fever - Pipeline Review, H1 2016’, provides an overview of the Lassa Fever pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lassa Fever, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8197IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8197IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H1 2016

    Multiple Sclerosis - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2016’, provides an overview of the Multiple Sclerosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Multiple...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7962IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7962IDB
  • View Report: Research and Experts Market Report: Encephalopathy - Pipeline Review, H1 2016

    Encephalopathy - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Encephalopathy - Pipeline Review, H1 2016’, provides an overview of the Encephalopathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Encephalopathy,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8204IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8204IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8167IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8167IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: Behcet Disease - Pipeline Review, H1 2016

    Behcet Disease - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Behcet Disease - Pipeline Review, H1 2016’, provides an overview of the Behcet Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Behcet Disease,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8113IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8113IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7977IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7977IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2016

    Hepatocellular Carcinoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Hepatocellular Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7971IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7971IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma Global Clinical Trials Review, H1, 2016

    Burkitt Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Burkitt Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Burkitt...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3397CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3397CTIDB
  • View Report: Research and Experts Market Report: Thymus Cancer Global Clinical Trials Review, H1, 2016

    Thymus Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Thymus Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Thymus Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Thymus Cancer....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3393CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3393CTIDB
  • View Report: Research and Experts Market Report: Diabetic Foot Ulcers - Pipeline Review, H1 2016

    Diabetic Foot Ulcers - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H1 2016’, provides an overview of the Diabetic Foot Ulcers pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8021IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8021IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8002IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8002IDB
  • View Report: Research and Experts Market Report: Ebola Viral Infections - Pipeline Review, H1 2016

    Ebola Viral Infections - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Ebola Viral Infections - Pipeline Review, H1 2016’, provides an overview of the Ebola Viral Infections pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8001IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8001IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2016

    Follicular Lymphoma - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Follicular Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Follicular...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7999IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7999IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7997IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7997IDB
  • View Report: Research and Experts Market Report: Neuroblastoma - Pipeline Review, H1 2016

    Neuroblastoma - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Neuroblastoma - Pipeline Review, H1 2016’, provides an overview of the Neuroblastoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Neuroblastoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7996IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7996IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2016

    Metastatic Colorectal Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7985IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7985IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2016

    Myelodysplastic Syndrome - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7984IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7984IDB
  • View Report: Research and Experts Market Report: Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor...

    Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor C or Retinoid-Related Orphan Receptor-Gamma or RORC) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor C or Retinoid-Related Orphan Receptor-Gamma or RORC) - Pipeline Review, H1 2016’,...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0036TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0036TDB
  • View Report: Research and Experts Market Report: Chondrosarcoma - Pipeline Review, H1 2016

    Chondrosarcoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Chondrosarcoma - Pipeline Review, H1 2016’, provides an overview of the Chondrosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chondrosarcoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8062IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8062IDB
  • View Report: Research and Experts Market Report: Ewing Sarcoma - Pipeline Review, H1 2016

    Ewing Sarcoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Ewing Sarcoma - Pipeline Review, H1 2016’, provides an overview of the Ewing Sarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ewing Sarcoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8034IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8034IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathy - Pipeline Review, H1 2016

    Diabetic Neuropathy - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Diabetic Neuropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8033IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8033IDB
  • View Report: Research and Experts Market Report: Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2016

    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2016’, provides an overview of the Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) pipeline landscape....
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8029IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8029IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8019IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8019IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8017IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8017IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2016

    Psoriatic Arthritis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2016’, provides an overview of the Psoriatic Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8010IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8010IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7986IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7986IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2016

    Tuberculosis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2016’, provides an overview of the Tuberculosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Tuberculosis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7976IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7976IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2016

    Malaria - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2016’, provides an overview of the Malaria pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Malaria, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7969IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7969IDB
  • View Report: Research and Experts Market Report: Gliosarcoma - Pipeline Review, H1 2016

    Gliosarcoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Gliosarcoma - Pipeline Review, H1 2016’, provides an overview of the Gliosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gliosarcoma, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8049IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8049IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2016’, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8015IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8015IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2016

    Systemic Lupus Erythematosus - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2016’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7998IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7998IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7978IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7978IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016

    Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia Global Clinical Trials Review, H1, 2016" provides an overview of Waldenstrom Macroglobulinemia clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3387CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3387CTIDB
  • View Report: Research and Experts Market Report: Myelofibrosis Global Clinical Trials Review, H1, 2016

    Myelofibrosis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H1, 2016" provides an overview of Myelofibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3385CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3385CTIDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis Global Clinical Trials Review, H1, 2016

    Psoriatic Arthritis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Psoriatic Arthritis Global Clinical Trials Review, H1, 2016" provides an overview of Psoriatic Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3384CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3384CTIDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2016

    Bladder Cancer - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Bladder Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bladder Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7982IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7982IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7820IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7820IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7818IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7818IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2016

    Ulcerative Colitis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2016’, provides an overview of the Ulcerative Colitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ulcerative...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7601IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7601IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev's Disease) Global Clinical Trials Review, H1, 2016" provides an overview of Ankylosing Spondylitis (Bekhterev's Disease) clinical trials scenario. This report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3334CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3334CTIDB
  • View Report: Research and Experts Market Report: Eosinophilic Esophagitis - Pipeline Review, H1 2016

    Eosinophilic Esophagitis - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Eosinophilic Esophagitis - Pipeline Review, H1 2016’, provides an overview of the Eosinophilic Esophagitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7914IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7914IDB
  • View Report: Research and Experts Market Report: Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2016

    Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Pancreatic Ductal Adenocarcinoma - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Ductal Adenocarcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7844IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7844IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016

    Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2016’, provides an overview of the Waldenstrom Macroglobulinemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7840IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7840IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7817IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7817IDB
  • View Report: Research and Experts Market Report: Hepatitis C - Pipeline Review, H1 2016

    Hepatitis C - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2016’, provides an overview of the Hepatitis C pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7638IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7638IDB
  • View Report: Research and Experts Market Report: Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2016

    Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2016’, provides an overview of the Post-Polycythemia Vera Myelofibrosis (PPV-MF) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7902IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7902IDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma - Pipeline Review, H1 2016

    Rhabdomyosarcoma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H1 2016’, provides an overview of the Rhabdomyosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rhabdomyosarcoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7900IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7900IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H1 2016

    Oligodendroglioma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H1 2016’, provides an overview of the Oligodendroglioma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Oligodendroglioma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7861IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7861IDB
  • View Report: Research and Experts Market Report: Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016

    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2016’, provides an overview of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7848IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7848IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H1 2016

    Pulmonary Fibrosis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pulmonary...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7692IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7692IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2016

    Psoriasis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7686IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7686IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H1 2016

    Esophageal Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2016’, provides an overview of the Esophageal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Esophageal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7704IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7704IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2016

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7699IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7699IDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2016’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7729IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7729IDB
  • View Report: Research and Experts Market Report: Liver Fibrosis - Pipeline Review, H1 2016

    Liver Fibrosis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Liver Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Liver Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liver Fibrosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7709IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7709IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016

    Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Myelodysplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3328CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3328CTIDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016

    Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H1, 2016" provides an overview of Systemic Sclerosis (Scleroderma) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3327CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3327CTIDB
  • View Report: Research and Experts Market Report: Sarcoidosis Global Clinical Trials Review, H1, 2016

    Sarcoidosis Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Sarcoidosis Global Clinical Trials Review, H1, 2016" provides an overview of Sarcoidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Sarcoidosis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3323CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3323CTIDB
  • View Report: Research and Experts Industry Report: Celgene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

    Celgene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report


    2016-06-30
    Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive...
  • Industry Report
  • Pharmaceuticals
  • United States
  • $350.00
  • Report 05IK-AAFFB01E-0E38-4826-A652-F3 has a star rating of 4.4 out of 5
  • Go to More information on Report 05IK-AAFFB01E-0E38-4826-A652-F3
  • View Report: Research and Experts Market Report: Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016

    Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2016’, provides an overview of the Metastatic Hepatocellular Carcinoma (HCC) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7726IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7726IDB
  • View Report: Research and Experts Market Report: Nasopharyngeal Cancer - Pipeline Review, H1 2016

    Nasopharyngeal Cancer - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H1 2016’, provides an overview of the Nasopharyngeal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7718IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7718IDB
  • View Report: Research and Experts Market Report: Radiculopathy Global Clinical Trials Review, H1, 2016

    Radiculopathy Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, H1, 2016" provides an overview of Radiculopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Radiculopathy....
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3296CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3296CTIDB
  • View Report: Research and Experts Market Report: Dysphagia Global Clinical Trials Review, H1, 2016

    Dysphagia Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Dysphagia Global Clinical Trials Review, H1, 2016" provides an overview of Dysphagia clinical trials scenario. This report provides top line data relating to the clinical trials on Dysphagia. Report...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3285CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3285CTIDB
  • View Report: Research and Experts Market Report: Cholangitis Global Clinical Trials Review, H1, 2016

    Cholangitis Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Cholangitis Global Clinical Trials Review, H1, 2016" provides an overview of Cholangitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholangitis. Report...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3277CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3277CTIDB
  • View Report: Research and Experts Market Report: Erosive Oral Lichen Planus Global Clinical Trials Review, H1, 2016

    Erosive Oral Lichen Planus Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Erosive Oral Lichen Planus Global Clinical Trials Review, H1, 2016" provides an overview of Erosive Oral Lichen Planus clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3272CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3272CTIDB
  • View Report: Research and Experts Market Report: Osteosarcoma - Pipeline Review, H1 2016

    Osteosarcoma - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H1 2016’, provides an overview of the Osteosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteosarcoma, complete...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7808IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7808IDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer - Pipeline Review, H1 2016

    Medullary Thyroid Cancer - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H1 2016’, provides an overview of the Medullary Thyroid Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7748IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7748IDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024


    2016-01-01
    Vasculitis is a family of rare autoimmune diseases, causing inflammation of the blood vessels, arteries, veins or capillaries. The different forms of vasculitis are classified by the size and location of the affected blood vessels . This report specifical...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC045POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC045POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: B-Cell Non-Hodgkin

    OpportunityAnalyzer: B-Cell Non-Hodgkin's Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024


    2016-01-01
    Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen....
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC018POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC018POA
  • View Report: Research and Experts Company Reports: Gilead Sciences, Inc. (GILD) - Medical Equipment - Deals and Alliances Profile

    Gilead Sciences, Inc. (GILD) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative medicines for diseases with unmet medical need. The company offers products in various therapeutic...
  • Company Reports
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME5315D has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDME5315D
  • View Report: Research and Experts Company Reports: Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile

    Amgen Inc. (AMGN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Amgen Inc. (Amgen) is a biotechnology company. It undertakes the discovery, development, manufacture and commercialization of innovative human therapeutics. The company pioneered the development of new products based on advances in recombinant DNA and...
  • Company Reports
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME3778D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME3778D
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H1 2016

    Indolent Lymphoma - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7663IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7663IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2016’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7660IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7660IDB
  • View Report: Research and Experts Market Report: Amyloidosis - Pipeline Review, H1 2016

    Amyloidosis - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Amyloidosis - Pipeline Review, H1 2016’, provides an overview of the Amyloidosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Amyloidosis, complete...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7646IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7646IDB
  • View Report: Research and Experts Market Report: Thrombocythaemia Myelofibrosis - Pipeline Review, H1 2016

    Thrombocythaemia Myelofibrosis - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Thrombocythaemia Myelofibrosis - Pipeline Review, H1 2016’, provides an overview of the Thrombocythaemia Myelofibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7665IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7665IDB
  • View Report: Research and Experts Market Report: Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016

    Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Diabetic Peripheral Neuropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Construction Materials
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7649IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7649IDB
  • View Report: Research and Experts Market Report: Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H1, 2016

    Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H1, 2016" provides an overview of Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) clinical trials scenario....
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3224CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3224CTIDB
  • View Report: Research and Experts Market Report: Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016

    Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of Neuroendocrine Carcinoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Construction Materials
  • Global
  • $2,500.00
  • Report 05IC-GDHC3215CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3215CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Systemic Sclerosis (Scleroderma) - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Systemic Sclerosis (Scleroderma) - Opportunity Analysis and Forecast to 2024


    2015-12-10
    Systemic sclerosis (SSc) is a complex autoimmune disease that affects the skin and multiple internal organs. Common manifestations of SSc that are included in this report are skin fibrosis, lung fibrosis, and digital vasculopathy (including Raynaud’s...
  • Market Report
  • Construction Materials
  • Global
  • $10,995.00
  • Report 05IC-GDHC044POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC044POA
  • View Report: Research and Experts Market Report: Uveitis Global Clinical Trials Review, H1, 2016

    Uveitis Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Uveitis Global Clinical Trials Review, H1, 2016" provides an overview of Uveitis clinical trials scenario. This report provides top line data relating to the clinical trials on Uveitis. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3212CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3212CTIDB
  • View Report: Research and Experts Market Report: Sezary Syndrome Global Clinical Trials Review, H1, 2016

    Sezary Syndrome Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Sezary Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Sezary...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3210CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3210CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024


    2015-12-01
    Acute myeloid (myelogenous, myelocytic) leukemia (AML) is a rapidly progressing blood cancer with an extremely poor overall prognosis. AML predominantly affects the elderly population and this subgroup of patients has an exceptionally high level of unmet...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC051POA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC051POA
  • View Report: Research and Experts Market Report: PharmaPoint: Multiple Myeloma - Global Drug Forecast and Market Analysis to 2023

    PharmaPoint: Multiple Myeloma - Global Drug Forecast and Market Analysis to 2023


    2015-11-01
    The Multiple Myeloma (MM) market is currently dominated by Velcade and Revlimid, and the market is set to undergo substantial growth between 2013 and 2023. The main drivers of growth will be the launch of monoclonal antibodies (mAbs) Empliciti and daratum...
  • Market Report
  • Healthcare
  • Global
  • $10,995.00
  • Report 05IC-GDHC114PIDR has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC114PIDR
  • View Report: Research and Experts Market Report: Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015

    Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015" provides an overview of Mycobacterium avium-Intracellulare Infections clinical trials scenario. This report provides...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3184CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3184CTIDB
  • View Report: Research and Experts Market Report: Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015

    Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015" provides an overview of Complicated Skin And Skin Structure Infections (cSSSI) clinical trials scenario....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3183CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3183CTIDB
  • View Report: Research and Experts Market Report: Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015

    Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015" provides an overview of Chlamydia trachomatis Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3182CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3182CTIDB
  • View Report: Research and Experts Market Report: Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015

    Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015" provides an overview of Skin And Skin Structure Infections (SSSI) Caused By Bacteria clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3181CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3181CTIDB
  • View Report: Research and Experts Market Report: Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015

    Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015" provides an overview of Staphylococcus aureus Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3180CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3180CTIDB
  • View Report: Research and Experts Market Report: Streptococcal Infections Global Clinical Trials Review, H2, 2015

    Streptococcal Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Streptococcal Infections Global Clinical Trials Review, H2, 2015" provides an overview of Streptococcal Infections clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3179CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3179CTIDB
  • View Report: Research and Experts Market Report: Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015

    Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015" provides an overview of Haemophilus influenzae Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3178CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3178CTIDB
  • View Report: Research and Experts Market Report: Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015

    Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015" provides an overview of Pseudomonas aeruginosa Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3177CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3177CTIDB
  • View Report: Research and Experts Market Report: Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015

    Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015" provides an overview of Haemophilus influenzae Type B Infections clinical trials scenario. This report provides top line...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3176CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3176CTIDB
  • View Report: Research and Experts Market Report: Rotavirus Infections Global Clinical Trials Review, H2, 2015

    Rotavirus Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Rotavirus Infections Global Clinical Trials Review, H2, 2015" provides an overview of Rotavirus Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3175CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3175CTIDB
  • View Report: Research and Experts Market Report: Influenza B Infections Global Clinical Trials Review, H2, 2015

    Influenza B Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Influenza B Infections Global Clinical Trials Review, H2, 2015" provides an overview of Influenza B Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3174CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3174CTIDB
  • View Report: Research and Experts Market Report: Pandemic Influenza Global Clinical Trials Review, H2, 2015

    Pandemic Influenza Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Pandemic Influenza Global Clinical Trials Review, H2, 2015" provides an overview of Pandemic Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3173CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3173CTIDB
  • View Report: Research and Experts Market Report: Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015

    Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015" provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3172CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3172CTIDB
  • View Report: Research and Experts Market Report: Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015

    Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015" provides an overview of Neisseria meningitidis Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3171CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3171CTIDB
  • View Report: Research and Experts Market Report: Influenza A Infections Global Clinical Trials Review, H2, 2015

    Influenza A Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Influenza A Infections Global Clinical Trials Review, H2, 2015" provides an overview of Influenza A Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3170CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3170CTIDB
  • View Report: Research and Experts Market Report: Chronic Bacterial Prostatitis Global Clinical Trials Review, H2, 2015

    Chronic Bacterial Prostatitis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Chronic Bacterial Prostatitis Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Bacterial Prostatitis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3169CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3169CTIDB
  • View Report: Research and Experts Market Report: Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015

    Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015" provides an overview of Epstein-Barr Viral Infections clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3168CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3168CTIDB
  • View Report: Research and Experts Market Report: Clostridium Infections Global Clinical Trials Review, H2, 2015

    Clostridium Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Clostridium Infections Global Clinical Trials Review, H2, 2015" provides an overview of Clostridium Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3167CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3167CTIDB
  • View Report: Research and Experts Market Report: Hepatitis Global Clinical Trials Review, H2, 2015

    Hepatitis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3166CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3166CTIDB
  • View Report: Research and Experts Market Report: Seasonal Influenza Global Clinical Trials Review, H2, 2015

    Seasonal Influenza Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Seasonal Influenza Global Clinical Trials Review, H2, 2015" provides an overview of Seasonal Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3165CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3165CTIDB
  • View Report: Research and Experts Market Report: Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015

    Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015" provides an overview of Hand, Foot And Mouth Disease clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3164CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3164CTIDB
  • View Report: Research and Experts Market Report: Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2015

    Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2015" provides an overview of Hemophagocytic Lymphohistiocytosis clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3163CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3163CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Global Clinical Trials Review, H2, 2015

    Osteoarthritis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H2, 2015" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3162CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3162CTIDB
  • View Report: Research and Experts Market Report: Measles Global Clinical Trials Review, H2, 2015

    Measles Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Measles Global Clinical Trials Review, H2, 2015" provides an overview of Measles clinical trials scenario. This report provides top line data relating to the clinical trials on Measles. Report includes...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3161CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3161CTIDB
  • View Report: Research and Experts Market Report: Brucellosis Global Clinical Trials Review, H2, 2015

    Brucellosis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Brucellosis Global Clinical Trials Review, H2, 2015" provides an overview of Brucellosis clinical trials scenario. This report provides top line data relating to the clinical trials on Brucellosis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3160CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3160CTIDB
  • View Report: Research and Experts Market Report: Vaginitis Global Clinical Trials Review, H2, 2015

    Vaginitis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Vaginitis Global Clinical Trials Review, H2, 2015" provides an overview of Vaginitis clinical trials scenario. This report provides top line data relating to the clinical trials on Vaginitis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3159CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3159CTIDB
  • View Report: Research and Experts Market Report: Mumps Global Clinical Trials Review, H2, 2015

    Mumps Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Mumps Global Clinical Trials Review, H2, 2015" provides an overview of Mumps clinical trials scenario. This report provides top line data relating to the clinical trials on Mumps. Report includes an...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3158CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3158CTIDB
  • View Report: Research and Experts Market Report: Rubella Global Clinical Trials Review, H2, 2015

    Rubella Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Rubella Global Clinical Trials Review, H2, 2015" provides an overview of Rubella clinical trials scenario. This report provides top line data relating to the clinical trials on Rubella. Report includes...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3157CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3157CTIDB
  • View Report: Research and Experts Market Report: Corneal Graft Rejection Global Clinical Trials Review, H2, 2015

    Corneal Graft Rejection Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Corneal Graft Rejection Global Clinical Trials Review, H2, 2015" provides an overview of Corneal Graft Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3156CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3156CTIDB
  • View Report: Research and Experts Market Report: Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015

    Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015" provides an overview of Drug Hypersensitivity Reactions clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3155CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3155CTIDB
  • View Report: Research and Experts Market Report: Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2015

    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2015" provides an overview of Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3154CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3154CTIDB
  • View Report: Research and Experts Market Report: Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015

    Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015" provides an overview of Hematopoietic Stem Cell Transplantation clinical trials scenario. This report provides top line...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3153CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3153CTIDB
  • View Report: Research and Experts Market Report: Allergies Global Clinical Trials Review, H2, 2015

    Allergies Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Allergies Global Clinical Trials Review, H2, 2015" provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3152CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3152CTIDB
  • View Report: Research and Experts Market Report: Chronic Inflammation Global Clinical Trials Review, H2, 2015

    Chronic Inflammation Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Chronic Inflammation Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3151CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3151CTIDB
  • View Report: Research and Experts Market Report: Myelofibrosis Global Clinical Trials Review, H2, 2015

    Myelofibrosis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H2, 2015" provides an overview of Myelofibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3150CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3150CTIDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015


    2015-10-30
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015’, provides an overview of the Ankylosing Spondylitis...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7227IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7227IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2015

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2015


    2015-10-30
    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2015’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7213IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7213IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-10-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7212IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7212IDB
  • View Report: Research and Experts Market Report: Liver Fibrosis - Pipeline Review, H2 2015

    Liver Fibrosis - Pipeline Review, H2 2015


    2015-10-28
    Liver Fibrosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Liver Fibrosis - Pipeline Review, H2 2015’, provides an overview of the Liver Fibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7289IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7289IDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma - Pipeline Review, H2 2015

    Rhabdomyosarcoma - Pipeline Review, H2 2015


    2015-10-28
    Rhabdomyosarcoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H2 2015’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7267IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7267IDB
  • View Report: Research and Experts Market Report: Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015

    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015


    2015-10-21
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2015’,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7245IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7245IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H2 2015

    Esophageal Cancer - Pipeline Review, H2 2015


    2015-10-21
    Esophageal Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H2 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6962IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6962IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Mantle Cell Lymphoma - Pipeline Review, H2 2015


    2015-10-21
    Mantle Cell Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6961IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6961IDB
  • View Report: Research and Experts Market Report: Amyloidosis - Pipeline Review, H2 2015

    Amyloidosis - Pipeline Review, H2 2015


    2015-10-14
    Amyloidosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Amyloidosis - Pipeline Review, H2 2015’, provides an overview of the Amyloidosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6855IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6855IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Refractory Multiple Myeloma - Pipeline Review, H2 2015


    2015-09-30
    Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H2 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7074IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7074IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H2 2015

    Oligodendroglioma - Pipeline Review, H2 2015


    2015-09-30
    Oligodendroglioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2015’, provides an overview of the Oligodendroglioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7173IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7173IDB
  • View Report: Research and Experts Market Report: Myelofibrosis - Pipeline Review, H2 2015

    Myelofibrosis - Pipeline Review, H2 2015


    2015-09-30
    Myelofibrosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Myelofibrosis - Pipeline Review, H2 2015’, provides an overview of the Myelofibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6980IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6980IDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015

    Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015


    2015-09-30
    Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6973IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6973IDB
  • View Report: Research and Experts Market Report: Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015

    Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015


    2015-09-23
    Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H2 2015’, provides an overview of the Peripheral Artery Occlusive Disease...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7084IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7084IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-09-23
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7077IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7077IDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer - Pipeline Review, H2 2015

    Medullary Thyroid Cancer - Pipeline Review, H2 2015


    2015-09-16
    Medullary Thyroid Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H2 2015’, provides an overview of the Medullary Thyroid Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7126IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7126IDB
  • View Report: Research and Experts Market Report: Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2015

    Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2015


    2015-09-16
    Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2015’, provides an overview of the Metastatic Hepatocellular Carcinoma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7123IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7123IDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015


    2015-09-16
    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7108IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7108IDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia - Pipeline Review, H2 2015

    T-Cell Leukemia - Pipeline Review, H2 2015


    2015-09-16
    T-Cell Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H2 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7107IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7107IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015


    2015-09-16
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7098IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7098IDB
  • View Report: Research and Experts Market Report: Sarcoidosis - Pipeline Review, H2 2015

    Sarcoidosis - Pipeline Review, H2 2015


    2015-09-09
    Sarcoidosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Sarcoidosis - Pipeline Review, H2 2015’, provides an overview of the Sarcoidosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7134IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC7134IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Systemic Lupus Erythematosus - Pipeline Review, H2 2015


    2015-08-31
    Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7059IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7059IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015


    2015-08-31
    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2015’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6990IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6990IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2015

    Indolent Lymphoma - Pipeline Review, H2 2015


    2015-08-31
    Indolent Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6983IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6983IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2015

    Gastric Cancer - Pipeline Review, H2 2015


    2015-08-26
    Gastric Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7055IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7055IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma - Pipeline Review, H2 2015

    Hodgkin Lymphoma - Pipeline Review, H2 2015


    2015-08-19
    Hodgkin Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Hodgkin Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7052IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7052IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2015

    Bladder Cancer - Pipeline Review, H2 2015


    2015-07-31
    Bladder Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H2 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6939IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6939IDB
  • View Report: Research and Experts Market Report: Nasopharyngeal Cancer - Pipeline Review, H2 2015

    Nasopharyngeal Cancer - Pipeline Review, H2 2015


    2015-07-31
    Nasopharyngeal Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H2 2015’, provides an overview of the Nasopharyngeal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6863IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6863IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2015

    Metastatic Breast Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6507IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6507IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-06-30
    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6676IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6676IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2015

    Liver Cancer - Pipeline Review, H1 2015


    2015-06-30
    Liver Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6563IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6563IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015


    2015-06-30
    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6505IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6505IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Metastatic Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6570IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6570IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Chronic Lymphocytic Leukemia (CLL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6567IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6567IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Hepatocellular Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6499IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6499IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2015

    Malaria - Pipeline Review, H1 2015


    2015-06-30
    Malaria - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2015’, provides an overview of the Malaria’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6677IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6677IDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2015

    Osteoarthritis - Pipeline Review, H1 2015


    2015-06-30
    Osteoarthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6571IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6571IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis - Pipeline Review, H1 2015

    Atopic Dermatitis - Pipeline Review, H1 2015


    2015-06-30
    Atopic Dermatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Atopic Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Atopic Dermatitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6513IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6513IDB
  • View Report: Research and Experts Market Report: Neuroblastoma - Pipeline Review, H1 2015

    Neuroblastoma - Pipeline Review, H1 2015


    2015-06-30
    Neuroblastoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuroblastoma - Pipeline Review, H1 2015’, provides an overview of the Neuroblastoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6575IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6575IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-06-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6519IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6519IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6518IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6518IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6516IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6516IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-24
    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Refractory Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6697IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6697IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2015

    Follicular Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Follicular Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6690IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6690IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Systemic Lupus Erythematosus - Pipeline Review, H1 2015


    2015-06-24
    Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6687IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6687IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Myelodysplastic Syndrome - Pipeline Review, H1 2015


    2015-06-24
    Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6685IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6685IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6684IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6684IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2015

    Bladder Cancer - Pipeline Review, H1 2015


    2015-06-24
    Bladder Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6683IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6683IDB
  • View Report: Research and Experts Market Report: Chondrosarcoma - Pipeline Review, H1 2015

    Chondrosarcoma - Pipeline Review, H1 2015


    2015-06-17
    Chondrosarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chondrosarcoma - Pipeline Review, H1 2015’, provides an overview of the Chondrosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6802IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6802IDB
  • View Report: Research and Experts Market Report: Gliosarcoma - Pipeline Review, H1 2015

    Gliosarcoma - Pipeline Review, H1 2015


    2015-06-17
    Gliosarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gliosarcoma - Pipeline Review, H1 2015’, provides an overview of the Gliosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6801IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6801IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-17
    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Relapsed Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6699IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6699IDB
  • View Report: Research and Experts Market Report: Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015

    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015


    2015-06-10
    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H1 2015’, provides...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6712IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6712IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015


    2015-06-10
    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6705IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6705IDB
  • View Report: Research and Experts Market Report: Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Soft Tissue Sarcoma - Pipeline Review, H1 2015


    2015-05-29
    Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Soft Tissue Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Soft Tissue Sarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6580IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6580IDB
  • View Report: Research and Experts Market Report: Psoriatic Arthritis - Pipeline Review, H1 2015

    Psoriatic Arthritis - Pipeline Review, H1 2015


    2015-05-29
    Psoriatic Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriatic Arthritis - Pipeline Review, H1 2015’, provides an overview of the Psoriatic Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6589IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6589IDB
  • View Report: Research and Experts Market Report: Diabetic Foot Ulcers - Pipeline Review, H1 2015

    Diabetic Foot Ulcers - Pipeline Review, H1 2015


    2015-05-29
    Diabetic Foot Ulcers - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H1 2015’, provides an overview of the Diabetic Foot Ulcers’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6588IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6588IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015


    2015-05-29
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015’, provides an overview of the Ankylosing Spondylitis...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6532IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6532IDB
  • View Report: Research and Experts Market Report: Rosacea - Pipeline Review, H1 2015

    Rosacea - Pipeline Review, H1 2015


    2015-04-30
    Rosacea - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rosacea - Pipeline Review, H1 2015’, provides an overview of the Rosacea’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6606IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6606IDB
  • View Report: Research and Experts Market Report: Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015

    Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015


    2015-04-30
    Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Waldenstrom Macroglobulinemia - Pipeline Review, H1 2015’, provides an overview of the Waldenstrom Macroglobulinemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6603IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6603IDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Relapsed Multiple Myeloma - Pipeline Review, H1 2015


    2015-03-31
    Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Relapsed Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6247IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6247IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2015

    Gastric Cancer - Pipeline Review, H1 2015


    2015-03-31
    Gastric Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6238IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6238IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015


    2015-03-26
    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Idiopathic Pulmonary Fibrosis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6473IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6473IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2015

    Psoriasis - Pipeline Review, H1 2015


    2015-03-26
    Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6361IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6361IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H1 2015

    Oligodendroglioma - Pipeline Review, H1 2015


    2015-03-19
    Oligodendroglioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H1 2015’, provides an overview of the Oligodendroglioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6462IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6462IDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma - Pipeline Review, H1 2015

    Rhabdomyosarcoma - Pipeline Review, H1 2015


    2015-03-19
    Rhabdomyosarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H1 2015’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6429IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6429IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-03-19
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6250IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6250IDB
  • View Report: Research and Experts Market Report: Dermatitis - Pipeline Review, H1 2015

    Dermatitis - Pipeline Review, H1 2015


    2015-03-19
    Dermatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Dermatitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6240IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6240IDB
  • View Report: Research and Experts Market Report: Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

    Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015


    2015-03-11
    Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview of the Peripheral Artery Occlusive Disease...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6257IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6257IDB
  • View Report: Research and Experts Market Report: Liver Fibrosis - Pipeline Review, H1 2015

    Liver Fibrosis - Pipeline Review, H1 2015


    2015-02-28
    Liver Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver fibrosis - Pipeline Review, H1 2015’, provides an overview of the Liver fibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6351IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6351IDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015


    2015-02-24
    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6281IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6281IDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia - Pipeline Review, H1 2015

    T-Cell Leukemia - Pipeline Review, H1 2015


    2015-02-24
    T-Cell Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6280IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6280IDB
  • View Report: Research and Experts Market Report: Sarcoidosis - Pipeline Review, H1 2015

    Sarcoidosis - Pipeline Review, H1 2015


    2015-02-18
    Sarcoidosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Sarcoidosis - Pipeline Review, H1 2015’, provides an overview of the Sarcoidosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6308IDB has a star rating of 3.1 out of 5
  • Go to More information on Report 05IB-GMDHC6308IDB
  • View Report: Research and Experts Market Report: Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015

    Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015


    2015-02-18
    Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2015’, provides an overview of the Metastatic Hepatocellular Carcinoma...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6297IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6297IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H1 2015

    Esophageal Cancer - Pipeline Review, H1 2015


    2015-01-30
    Esophageal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6140IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6140IDB
  • View Report: Research and Experts Market Report: Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Mantle Cell Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Mantle Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6139IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6139IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H1 2015

    Refractory Multiple Myeloma - Pipeline Review, H1 2015


    2015-01-30
    Refractory Multiple Myeloma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6135IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6135IDB
  • View Report: Research and Experts Market Report: Hepatitis C - Pipeline Review, H1 2015

    Hepatitis C - Pipeline Review, H1 2015


    2015-01-30
    Hepatitis C - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2015’, provides an overview of the Hepatitis C’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6008IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6008IDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015

    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015


    2015-01-30
    B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2015’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6168IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6168IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H1 2015

    Indolent Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Indolent Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6162IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6162IDB
  • View Report: Research and Experts Market Report: Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-01-30
    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6161IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6161IDB
  • View Report: Research and Experts Market Report: Myelofibrosis - Pipeline Review, H1 2015

    Myelofibrosis - Pipeline Review, H1 2015


    2015-01-30
    Myelofibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelofibrosis - Pipeline Review, H1 2015’, provides an overview of the Myelofibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6159IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6159IDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015

    Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015


    2015-01-30
    Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2015’, provides an overview of the Systemic Sclerosis (Scleroderma)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6152IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6152IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2015

    Metastatic Melanoma - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6013IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6013IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H1 2015

    Head And Neck Cancer - Pipeline Review, H1 2015


    2015-01-30
    Head And Neck Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6010IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6010IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2015

    Ulcerative Colitis - Pipeline Review, H1 2015


    2015-01-22
    Ulcerative Colitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2015’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6015IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6015IDB
  • View Report: Research and Experts Market Report: Amyloidosis - Pipeline Review, H1 2015

    Amyloidosis - Pipeline Review, H1 2015


    2015-01-22
    Amyloidosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Amyloidosis - Pipeline Review, H1 2015’, provides an overview of the Amyloidosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6041IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6041IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015


    2015-01-22
    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6022IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6022IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H1 2015

    Pulmonary Fibrosis - Pipeline Review, H1 2015


    2015-01-22
    Pulmonary Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6017IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6017IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2015

    Breast Cancer - Pipeline Review, H1 2015


    2015-01-22
    Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6006IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6006IDB
  • View Report: Research and Experts Market Report: Nasopharyngeal Cancer - Pipeline Review, H1 2015

    Nasopharyngeal Cancer - Pipeline Review, H1 2015


    2015-01-22
    Nasopharyngeal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H1 2015’, provides an overview of the Nasopharyngeal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-R03E53 has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-R03E53
  • View Report: Research and Experts Market Report: HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015

    HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of HIV-Associated Lipodystrophy Syndrome clinical trials scenario. This report provides top line data...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3149CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3149CTIDB
  • View Report: Research and Experts Market Report: Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015

    Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015" provides an overview of Lysosomal Storage Disorder clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3148CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3148CTIDB
  • View Report: Research and Experts Market Report: Cardiometabolic Disease Global Clinical Trials Review, H2, 2015

    Cardiometabolic Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Cardiometabolic Disease Global Clinical Trials Review, H2, 2015" provides an overview of Cardiometabolic Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3147CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3147CTIDB
  • View Report: Research and Experts Market Report: Homozygous Familial Hypercholesterolemia (HoFH) Global Clinical Trials Review, H2, 2015

    Homozygous Familial Hypercholesterolemia (HoFH) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Homozygous Familial Hypercholesterolemia (HoFH) Global Clinical Trials Review, H2, 2015" provides an overview of Homozygous Familial Hypercholesterolemia (HoFH) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3146CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3146CTIDB
  • View Report: Research and Experts Market Report: Diabetic Complications Global Clinical Trials Review, H2, 2015

    Diabetic Complications Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Diabetic Complications Global Clinical Trials Review, H2, 2015" provides an overview of Diabetic Complications clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3145CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3145CTIDB
  • View Report: Research and Experts Market Report: Hepatic Encephalopathy Global Clinical Trials Review, H2, 2015

    Hepatic Encephalopathy Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H2, 2015" provides an overview of Hepatic Encephalopathy clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3144CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3144CTIDB
  • View Report: Research and Experts Market Report: Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H2, 2015

    Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H2, 2015" provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3143CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3143CTIDB
  • View Report: Research and Experts Market Report: Urea Cycle Disorders Global Clinical Trials Review, H2, 2015

    Urea Cycle Disorders Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Urea Cycle Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Urea Cycle Disorders clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3142CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3142CTIDB
  • View Report: Research and Experts Market Report: Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015

    Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015" provides an overview of Heterozygous familial hypercholesterolemia (heFH) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3141CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3141CTIDB
  • View Report: Research and Experts Market Report: Lipid Disorders Global Clinical Trials Review, H2, 2015

    Lipid Disorders Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Lipid Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Lipid Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Lipid...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3140CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3140CTIDB
  • View Report: Research and Experts Market Report: Tendon and Ligament Pain Global Clinical Trials Review, H2, 2015

    Tendon and Ligament Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Tendon and Ligament Pain Global Clinical Trials Review, H2, 2015" provides an overview of Tendon and Ligament Pain clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3139CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3139CTIDB
  • View Report: Research and Experts Market Report: Visceral Pain Global Clinical Trials Review, H2, 2015

    Visceral Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Visceral Pain Global Clinical Trials Review, H2, 2015" provides an overview of Visceral Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Visceral Pain....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3138CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3138CTIDB
  • View Report: Research and Experts Market Report: Treatment Resistant Depression Global Clinical Trials Review, H2, 2015

    Treatment Resistant Depression Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Treatment Resistant Depression Global Clinical Trials Review, H2, 2015" provides an overview of Treatment Resistant Depression clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3137CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3137CTIDB
  • View Report: Research and Experts Market Report: Resistant Hypertension Global Clinical Trials Review, H2, 2015

    Resistant Hypertension Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Resistant Hypertension Global Clinical Trials Review, H2, 2015" provides an overview of Resistant Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3136CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3136CTIDB
  • View Report: Research and Experts Market Report: Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015

    Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015" provides an overview of Post-Myocardial Infarction clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3135CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3135CTIDB
  • View Report: Research and Experts Market Report: Thromboembolic Disease Global Clinical Trials Review, H2, 2015

    Thromboembolic Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Thromboembolic Disease Global Clinical Trials Review, H2, 2015" provides an overview of Thromboembolic Disease clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3134CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3134CTIDB
  • View Report: Research and Experts Market Report: Vaso-Occlusive Crisis Associated With Sickle Cell Disease Global Clinical Trials Review, H2, 2015

    Vaso-Occlusive Crisis Associated With Sickle Cell Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Vaso-Occlusive Crisis Associated With Sickle Cell Disease Global Clinical Trials Review, H2, 2015" provides an overview of Vaso-Occlusive Crisis Associated With Sickle Cell Disease clinical trials scenario....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3133CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3133CTIDB
  • View Report: Research and Experts Market Report: Percutaneous Coronary Intervention Global Clinical Trials Review, H2, 2015

    Percutaneous Coronary Intervention Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Percutaneous Coronary Intervention Global Clinical Trials Review, H2, 2015" provides an overview of Percutaneous Coronary Intervention clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3132CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3132CTIDB
  • View Report: Research and Experts Market Report: Systolic Heart Failure Global Clinical Trials Review, H2, 2015

    Systolic Heart Failure Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Systolic Heart Failure Global Clinical Trials Review, H2, 2015" provides an overview of Systolic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3131CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3131CTIDB
  • View Report: Research and Experts Market Report: Patent Ductus Arteriosus Global Clinical Trials Review, H2, 2015

    Patent Ductus Arteriosus Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Patent Ductus Arteriosus Global Clinical Trials Review, H2, 2015" provides an overview of Patent Ductus Arteriosus clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3130CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3130CTIDB
  • View Report: Research and Experts Market Report: Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2015

    Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2015" provides an overview of Deep Vein Thrombosis (DVT) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3129CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3129CTIDB
  • View Report: Research and Experts Market Report: Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2015

    Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2015" provides an overview of Hypertrophic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3128CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3128CTIDB
  • View Report: Research and Experts Market Report: Coronary Disease Global Clinical Trials Review, H2, 2015

    Coronary Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Coronary Disease Global Clinical Trials Review, H2, 2015" provides an overview of Coronary Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3127CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3127CTIDB
  • View Report: Research and Experts Market Report: Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015

    Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3126CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3126CTIDB
  • View Report: Research and Experts Market Report: Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015

    Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015" provides an overview of Non-ischemic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3125CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3125CTIDB
  • View Report: Research and Experts Market Report: Myocardial Infarction Global Clinical Trials Review, H2, 2015

    Myocardial Infarction Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Myocardial Infarction Global Clinical Trials Review, H2, 2015" provides an overview of Myocardial Infarction clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3124CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3124CTIDB
  • View Report: Research and Experts Market Report: Mitral Valve Diseases Global Clinical Trials Review, H2, 2015

    Mitral Valve Diseases Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Mitral Valve Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Mitral Valve Diseases clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3123CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3123CTIDB
  • View Report: Research and Experts Market Report: Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2015

    Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2015" provides an overview of Hepatic Veno Occlusive Disease clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3122CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3122CTIDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015

    Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3121CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3121CTIDB
  • View Report: Research and Experts Market Report: Cardiac Arrest Global Clinical Trials Review, H2, 2015

    Cardiac Arrest Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Cardiac Arrest Global Clinical Trials Review, H2, 2015" provides an overview of Cardiac Arrest clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiac...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3120CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3120CTIDB
  • View Report: Research and Experts Market Report: Secondary Progressive Multiple Sclerosis (SPMS) Global Clinical Trials Review, H2, 2015

    Secondary Progressive Multiple Sclerosis (SPMS) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Secondary Progressive Multiple Sclerosis (SPMS) Global Clinical Trials Review, H2, 2015" provides an overview of Secondary Progressive Multiple Sclerosis (SPMS) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3119CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3119CTIDB
  • View Report: Research and Experts Market Report: Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015

    Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015" provides an overview of Primary Progressive Multiple Sclerosis (PPMS) clinical trials scenario. This report provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3118CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3118CTIDB
  • View Report: Research and Experts Market Report: Post-Operative Pain Global Clinical Trials Review, H2, 2015

    Post-Operative Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Post-Operative Pain Global Clinical Trials Review, H2, 2015" provides an overview of Post-Operative Pain clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3117CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3117CTIDB
  • View Report: Research and Experts Market Report: Opium Withdrawal Syndrome Global Clinical Trials Review, H2, 2015

    Opium Withdrawal Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Opium Withdrawal Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Opium Withdrawal Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3116CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3116CTIDB
  • View Report: Research and Experts Market Report: Non Malignant pain Global Clinical Trials Review, H2, 2015

    Non Malignant pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Non Malignant pain Global Clinical Trials Review, H2, 2015" provides an overview of Non Malignant pain clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3115CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3115CTIDB
  • View Report: Research and Experts Market Report: Musculoskeletal Pain Global Clinical Trials Review, H2, 2015

    Musculoskeletal Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Musculoskeletal Pain Global Clinical Trials Review, H2, 2015" provides an overview of Musculoskeletal Pain clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3114CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3114CTIDB
  • View Report: Research and Experts Market Report: Pathological Gambling Global Clinical Trials Review, H2, 2015

    Pathological Gambling Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Pathological Gambling Global Clinical Trials Review, H2, 2015" provides an overview of Pathological Gambling clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3113CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3113CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain Global Clinical Trials Review, H2, 2015

    Osteoarthritis Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Osteoarthritis Pain Global Clinical Trials Review, H2, 2015" provides an overview of Osteoarthritis Pain clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3112CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3112CTIDB
  • View Report: Research and Experts Market Report: Neurotoxicity Syndromes Global Clinical Trials Review, H2, 2015

    Neurotoxicity Syndromes Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Neurotoxicity Syndromes Global Clinical Trials Review, H2, 2015" provides an overview of Neurotoxicity Syndromes clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3111CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3111CTIDB
  • View Report: Research and Experts Market Report: Neck Pain Global Clinical Trials Review, H2, 2015

    Neck Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Neck Pain Global Clinical Trials Review, H2, 2015" provides an overview of Neck Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Neck Pain. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3110CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3110CTIDB
  • View Report: Research and Experts Market Report: Chronic Cerebrospinal Venous Insufficiency (CCSVI) Global Clinical Trials Review, H2, 2015

    Chronic Cerebrospinal Venous Insufficiency (CCSVI) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Chronic Cerebrospinal Venous Insufficiency (CCSVI) Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Cerebrospinal Venous Insufficiency (CCSVI) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3109CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3109CTIDB
  • View Report: Research and Experts Market Report: Low Back Pain Global Clinical Trials Review, H2, 2015

    Low Back Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Low Back Pain Global Clinical Trials Review, H2, 2015" provides an overview of Low Back Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Low Back Pain....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3108CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3108CTIDB
  • View Report: Research and Experts Market Report: Cognitive Disorders Global Clinical Trials Review, H2, 2015

    Cognitive Disorders Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Cognitive Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Cognitive Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3107CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3107CTIDB
  • View Report: Research and Experts Market Report: Chronic Pain Global Clinical Trials Review, H2, 2015

    Chronic Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Chronic Pain Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Pain....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3106CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3106CTIDB
  • View Report: Research and Experts Market Report: Chronic Back Pain Global Clinical Trials Review, H2, 2015

    Chronic Back Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Chronic Back Pain Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Back Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3105CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3105CTIDB
  • View Report: Research and Experts Market Report: Psychotic Major Depression Global Clinical Trials Review, H2, 2015

    Psychotic Major Depression Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Psychotic Major Depression Global Clinical Trials Review, H2, 2015" provides an overview of Psychotic Major Depression clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3104CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3104CTIDB
  • View Report: Research and Experts Market Report: Memory Impairment Global Clinical Trials Review, H2, 2015

    Memory Impairment Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Memory Impairment Global Clinical Trials Review, H2, 2015" provides an overview of Memory Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Memory...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3103CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3103CTIDB
  • View Report: Research and Experts Market Report: Essential Tremor Global Clinical Trials Review, H2, 2015

    Essential Tremor Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Essential Tremor Global Clinical Trials Review, H2, 2015" provides an overview of Essential Tremor clinical trials scenario. This report provides top line data relating to the clinical trials on Essential...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3102CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3102CTIDB
  • View Report: Research and Experts Market Report: Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015

    Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015" provides an overview of Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) clinical trials scenario....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3101CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3101CTIDB
  • View Report: Research and Experts Market Report: Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2015

    Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2015" provides an overview of Cerebral Infarction (Brain Infarction) clinical trials scenario. This report provides top line...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3100CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3100CTIDB
  • View Report: Research and Experts Market Report: Brain Edema Global Clinical Trials Review, H2, 2015

    Brain Edema Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Brain Edema Global Clinical Trials Review, H2, 2015" provides an overview of Brain Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Edema. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3099CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3099CTIDB
  • View Report: Research and Experts Market Report: Binge Eating Disorder Global Clinical Trials Review, H2, 2015

    Binge Eating Disorder Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Binge Eating Disorder Global Clinical Trials Review, H2, 2015" provides an overview of Binge Eating Disorder clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3098CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3098CTIDB
  • View Report: Research and Experts Market Report: Acute Stress Disorder Global Clinical Trials Review, H2, 2015

    Acute Stress Disorder Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Acute Stress Disorder Global Clinical Trials Review, H2, 2015" provides an overview of Acute Stress Disorder clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3097CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3097CTIDB
  • View Report: Research and Experts Market Report: Childhood Epilepsy Global Clinical Trials Review, H2, 2015

    Childhood Epilepsy Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Childhood Epilepsy Global Clinical Trials Review, H2, 2015" provides an overview of Childhood Epilepsy clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3096CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3096CTIDB
  • View Report: Research and Experts Market Report: Bladder Pain Global Clinical Trials Review, H2, 2015

    Bladder Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Bladder Pain Global Clinical Trials Review, H2, 2015" provides an overview of Bladder Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Pain....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3095CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3095CTIDB
  • View Report: Research and Experts Market Report: Back Pain Global Clinical Trials Review, H2, 2015

    Back Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Back Pain Global Clinical Trials Review, H2, 2015" provides an overview of Back Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Back Pain. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3094CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3094CTIDB
  • View Report: Research and Experts Market Report: Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2015

    Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Appetite (Eating) Disorders clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3093CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3093CTIDB
  • View Report: Research and Experts Market Report: Complex Partial Seizure Global Clinical Trials Review, H2, 2015

    Complex Partial Seizure Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Complex Partial Seizure Global Clinical Trials Review, H2, 2015" provides an overview of Complex Partial Seizure clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3092CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3092CTIDB
  • View Report: Research and Experts Market Report: Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H2, 2015

    Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H2, 2015" provides an overview of Attention Deficit Hyperactivity Disorder (ADHD) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3091CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3091CTIDB
  • View Report: Research and Experts Market Report: Alcohol Withdrawal Syndrome Global Clinical Trials Review, H2, 2015

    Alcohol Withdrawal Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Alcohol Withdrawal Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Alcohol Withdrawal Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3090CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3090CTIDB
  • View Report: Research and Experts Market Report: Cholelithiasis Global Clinical Trials Review, H2, 2015

    Cholelithiasis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Cholelithiasis Global Clinical Trials Review, H2, 2015" provides an overview of Cholelithiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholelithiasis....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3089CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3089CTIDB
  • View Report: Research and Experts Market Report: Colonic Diverticulitis Global Clinical Trials Review, H2, 2015

    Colonic Diverticulitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Colonic Diverticulitis Global Clinical Trials Review, H2, 2015" provides an overview of Colonic Diverticulitis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3088CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3088CTIDB
  • View Report: Research and Experts Market Report: Proctitis Global Clinical Trials Review, H2, 2015

    Proctitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Proctitis Global Clinical Trials Review, H2, 2015" provides an overview of Proctitis clinical trials scenario. This report provides top line data relating to the clinical trials on Proctitis. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3087CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3087CTIDB
  • View Report: Research and Experts Market Report: Fecal Incontinence Global Clinical Trials Review, H2, 2015

    Fecal Incontinence Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Fecal Incontinence Global Clinical Trials Review, H2, 2015" provides an overview of Fecal Incontinence clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3086CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3086CTIDB
  • View Report: Research and Experts Market Report: Dyspepsia Global Clinical Trials Review, H2, 2015

    Dyspepsia Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Dyspepsia Global Clinical Trials Review, H2, 2015" provides an overview of Dyspepsia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspepsia. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3085CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3085CTIDB
  • View Report: Research and Experts Market Report: Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015

    Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3084CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3084CTIDB
  • View Report: Research and Experts Market Report: Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015

    Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Alcoholic Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3083CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3083CTIDB
  • View Report: Research and Experts Market Report: Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015

    Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015" provides an overview of Non Alcoholic Fatty Liver Disease (NAFLD) clinical trials scenario. This report provides top...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3082CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3082CTIDB
  • View Report: Research and Experts Market Report: Traveler

    Traveler's Diarrhea Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Traveler's Diarrhea Global Clinical Trials Review, H2, 2015" provides an overview of Traveler's Diarrhea clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3081CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3081CTIDB
  • View Report: Research and Experts Market Report: Systemic Mastocytosis Global Clinical Trials Review, H2, 2015

    Systemic Mastocytosis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Systemic Mastocytosis Global Clinical Trials Review, H2, 2015" provides an overview of Systemic Mastocytosis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3080CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3080CTIDB
  • View Report: Research and Experts Market Report: Steatohepatitis Global Clinical Trials Review, H2, 2015

    Steatohepatitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Steatohepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Steatohepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Steatohepatitis...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3079CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3079CTIDB
  • View Report: Research and Experts Market Report: Primary Biliary Cirrhosis Global Clinical Trials Review, H2, 2015

    Primary Biliary Cirrhosis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Primary Biliary Cirrhosis Global Clinical Trials Review, H2, 2015" provides an overview of Primary Biliary Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3078CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3078CTIDB
  • View Report: Research and Experts Market Report: Pouchitis Global Clinical Trials Review, H2, 2015

    Pouchitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Pouchitis Global Clinical Trials Review, H2, 2015" provides an overview of Pouchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Pouchitis. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3077CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3077CTIDB
  • View Report: Research and Experts Market Report: Nausea Global Clinical Trials Review, H2, 2015

    Nausea Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Nausea Global Clinical Trials Review, H2, 2015" provides an overview of Nausea clinical trials scenario. This report provides top line data relating to the clinical trials on Nausea. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3076CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3076CTIDB
  • View Report: Research and Experts Market Report: Liver Diseases Global Clinical Trials Review, H2, 2015

    Liver Diseases Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Liver Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Liver Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Diseases....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3075CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3075CTIDB
  • View Report: Research and Experts Market Report: Gastroparesis Global Clinical Trials Review, H2, 2015

    Gastroparesis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Gastroparesis Global Clinical Trials Review, H2, 2015" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3074CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3074CTIDB
  • View Report: Research and Experts Market Report: Jaundice Global Clinical Trials Review, H2, 2015

    Jaundice Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Jaundice Global Clinical Trials Review, H2, 2015" provides an overview of Jaundice clinical trials scenario. This report provides top line data relating to the clinical trials on Jaundice. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3073CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3073CTIDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2015" provides an overview of Crohn's Disease (Regional Enteritis) clinical trials scenario. This report provides top...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3072CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3072CTIDB
  • View Report: Research and Experts Market Report: Cirrhosis Global Clinical Trials Review, H2, 2015

    Cirrhosis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Cirrhosis Global Clinical Trials Review, H2, 2015" provides an overview of Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cirrhosis. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3071CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3071CTIDB
  • View Report: Research and Experts Market Report: Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) Global Clinical Trials Review, H2, 2015

    Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) Global Clinical Trials Review, H2, 2015" provides an overview of Atypical Hemolytic Uremic Syndrome (Nondiarrhea-...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3070CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3070CTIDB
  • View Report: Research and Experts Market Report: Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015

    Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015" provides an overview of Nonerosive Reflux Disease (NERD) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3069CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3069CTIDB
  • View Report: Research and Experts Market Report: Spontaneous Bacterial Peritonitis Global Clinical Trials Review, H2, 2015

    Spontaneous Bacterial Peritonitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Spontaneous Bacterial Peritonitis Global Clinical Trials Review, H2, 2015" provides an overview of Spontaneous Bacterial Peritonitis clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3068CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3068CTIDB
  • View Report: Research and Experts Market Report: Short Bowel Syndrome Global Clinical Trials Review, H2, 2015

    Short Bowel Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Short Bowel Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Short Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3067CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3067CTIDB
  • View Report: Research and Experts Market Report: Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2015

    Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2015" provides an overview of Primary Sclerosing Cholangitis clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3066CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC3066CTIDB
  • View Report: Research and Experts Market Report: Postoperative Ileus Global Clinical Trials Review, H2, 2015

    Postoperative Ileus Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Postoperative Ileus Global Clinical Trials Review, H2, 2015" provides an overview of Postoperative Ileus clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3065CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3065CTIDB
  • View Report: Research and Experts Market Report: Post Operative Nausea And Vomiting Global Clinical Trials Review, H2, 2015

    Post Operative Nausea And Vomiting Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Post Operative Nausea And Vomiting Global Clinical Trials Review, H2, 2015" provides an overview of Post Operative Nausea And Vomiting clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3064CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3064CTIDB
  • View Report: Research and Experts Company Reports: Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review

    Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review


    2016-06-01
    Vical Incorporated (Vical) is a biopharmaceutical company, which focuses on research and development on DNA delivery technologies for the prevention and treatment of life-threatening diseases and vaccines for infectious diseases and cardiovascular therapi...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH1730FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH1730FSA
  • View Report: Research and Experts Company Reports: NewLink Genetics Corporation (NLNK) - Financial and Strategic SWOT Analysis Review

    NewLink Genetics Corporation (NLNK) - Financial and Strategic SWOT Analysis Review


    2016-05-17
    NewLink Genetics Corporation (NewLink) is a biopharmaceutical company, which undertakes the discovery, development and commercialization of immunotherapeutic products for the treatment of cancer. NewLinks pipeline products include both biologic and small-...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH139865FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH139865FSA
  • View Report: Research and Experts Company Reports: CTI BioPharma Corp (CTIC) - Financial and Strategic SWOT Analysis Review

    CTI BioPharma Corp (CTIC) - Financial and Strategic SWOT Analysis Review


    2017-04-05
    CTI BioPharma Corp (CTI BioPharma) is a biopharmaceutical company, which acquires, develops, and commercializes targeted therapies for a range of blood-related cancers. The company’s lead product, Pixuvri (pixantrone) is an aza-anthracenedione that...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH34546FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH34546FSA
  • View Report: Research and Experts Company Reports: Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review

    Spectrum Pharmaceuticals Inc (SPPI) - Financial and Strategic SWOT Analysis Review


    2017-04-11
    Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with particular focus on hematology and oncology. The company’s marketed drugs include Fusilev...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH112072FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH112072FSA
  • View Report: Research and Experts Company Reports: Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review

    Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review


    2016-05-10
    Athersys, Inc. (Athersys) is a biotechnology company, which carries out the discovery and development of novel and proprietary best-in-class therapies in the field of regenerative medicine. Its lead platform, MultiStem, is a patented stem cell product,...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH4263FSA has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDPH4263FSA
  • View Report: Research and Experts Company Reports: Celldex Therapeutics, Inc. (CLDX) - Financial and Strategic SWOT Analysis Review

    Celldex Therapeutics, Inc. (CLDX) - Financial and Strategic SWOT Analysis Review


    2016-05-03
    Celldex Therapeutics, Inc. (Celldex) is a bio-pharmaceutical company. It undertakes the discovery, development and commercialization of vaccines and targeted immunotherapy technologies for the treatment of cancer and other devastating diseases. The compan...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH57234FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH57234FSA
  • View Report: Research and Experts Company Reports: Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review

    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review


    2017-04-19
    Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative medicines for diseases with unmet medical need. The company offers products in various therapeutic...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH5315FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH5315FSA
  • View Report: Research and Experts Company Reports: Seattle Genetics Inc (SGEN) - Financial and Strategic SWOT Analysis Review

    Seattle Genetics Inc (SGEN) - Financial and Strategic SWOT Analysis Review


    2017-03-21
    Seattle Genetics Inc (Seattle Genetics) is a biotechnology company that develops and commercializes monoclonal antibody-based therapies for the treatment of cancer. The company's lead product Adcetris (brentuximab vedotin) is an antibody-drug conjuga...
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH4301FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH4301FSA
  • View Report: Research and Experts Company Reports: Celgene Corp (CELG) - Financial and Strategic SWOT Analysis Review

    Celgene Corp (CELG) - Financial and Strategic SWOT Analysis Review


    2017-03-08
    Celgene Corp (Celgene) is an integrated global biopharmaceutical company that carries out the research, development, manufacture and marketing of novel therapies to treat cancer and immune-inflammatory related diseases through gene and protein regulation....
  • Company Reports
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH40041FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH40041FSA
  • View Report: Research and Experts Market Report: Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2015

    Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H2, 2015" provides an overview of Chemotherapy Induced Anemia clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2987CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC2987CTIDB
  • View Report: Research and Experts Market Report: Chronic Cough Global Clinical Trials Review, H2, 2015

    Chronic Cough Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Chronic Cough Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Cough clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Cough....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2977CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC2977CTIDB
  • View Report: Research and Experts Market Report: Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Global Clinical Trials Review, H2, 2015

    Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) Global Clinical Trials Review, H2, 2015" provides an overview of Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2976CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC2976CTIDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2015

    Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2015


    2015-11-30
    GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Myelodysplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3022CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3022CTIDB
  • View Report: Research and Experts Company Reports: Celgene Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report

    Celgene Corporation: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report


    2012-11-29
    ICD Research's "Celgene Corporation: Pharmaceuticals and Healthcare - Company Profile & SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts,major...
  • Company Reports
  • Pharmaceuticals
  • United States
  • $125.00
  • Report 01H3-ST01055CP has a star rating of 2.5 out of 5
  • Go to More information on Report 01H3-ST01055CP
  • Industries and Sectors

    • Oncology (83)
    • Gastrointestinal... (8)
    • Infectious Disease... (5)
    • Immunology (7)
    • Central Nervous... (6)
    • Pharmaceuticals (205)
    • Cardiovascular (5)
    • Life Sciences (109)
    • Metabolic Disorders... (5)
    • Musculoskeletal... (2)
    • Respiratory (3)
    • Hematology (1)
    • Dermatology (1)
    • Mouth And Dental... (1)
    • Healthcare (40)
    • Construction Materials... (16)
    • Medical Devices (2)

    Geographic Regions

    • Global (485)
    • United States (14)

    Report Types

    • Market Report (485)
    • Project Profile (1)
    • Industry Report (1)
    • Company Reports (12)

    Return to Company List

    Page created and rendered - Cache updated [5.24750s]

    --